Literature DB >> 7607643

Predisposition for cysteine substitutions in the immunoglobulin-like chain of FGFR2 in Crouzon syndrome.

D Steinberger1, J B Mulliken, U Müller.   

Abstract

Four cases of Crouzon syndrome, one familial and three sporadic, were investigated for mutations in exon B of the fibroblast growth factor receptor 2 (FGFR2) gene. In the familial case, a mutation was found at codon 340 that exchanged tyrosine for histidine. Mutations at codon 342, detected in the three sporadic cases, replaced a cysteine by another amino acid. While three of the mutations have been described before, the fourth mutation, a C-->G transversion at codon 342 in one of the sporadic cases, has not been recognized previously. Compilation of all exon B mutations in Crouzon syndrome described to date revealed that 6 of the 8 sporadic and 2 of the 9 familial cases have mutations in codon 342. These mutations caused the substitution of cysteine for another amino acid. Given that a mutation in codon 342 was found in 8 out of 17 cases and that in 9 cases the mutation occurred at five additional positions, codon 342 of exon B of the FGFR2 gene may be predisposed to mutations in Crouzon syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607643     DOI: 10.1007/BF00214198

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  [Crouzon's craniofacial dysostosis and syringomyèlia; association in brother and sister].

Authors:  G MORETTI; J STAEFFEN
Journal:  Presse Med       Date:  1959-02-25       Impact factor: 1.228

2.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10.

Authors:  R A Preston; J C Post; B J Keats; C E Aston; R E Ferrell; J Priest; N Nouri; H W Losken; C A Morris; M R Hurtt
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

4.  Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene.

Authors:  M Kostrzewa; U Burck-Lehmann; U Müller
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

5.  Crouzon Syndrome. A clinical and roentgencephalometric study.

Authors:  S Kreiborg
Journal:  Scand J Plast Reconstr Surg Suppl       Date:  1981

6.  Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.

Authors:  E W Jabs; X Li; A F Scott; G Meyers; W Chen; M Eccles; J I Mao; L R Charnas; C E Jackson; M Jaye
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

7.  Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.

Authors:  W Reardon; R M Winter; P Rutland; L J Pulleyn; B M Jones; S Malcolm
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

  7 in total
  12 in total

Review 1.  Fibroblast growth factor receptor mutations and craniosynostosis: three receptors, five syndromes.

Authors:  A O Wilkie
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

Review 2.  Molecular genetics of craniosynostotic syndromes.

Authors:  U Müller; D Steinberger; S Kunze
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

3.  Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.

Authors:  S F Slaney; M Oldridge; J A Hurst; G M Moriss-Kay; C M Hall; M D Poole; A O Wilkie
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

4.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 5.  FGF signaling in the developing endochondral skeleton.

Authors:  David M Ornitz
Journal:  Cytokine Growth Factor Rev       Date:  2005-04-01       Impact factor: 7.638

6.  A novel mutation (a886g) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly.

Authors:  D Steinberger; H Collmann; B Schmalenberger; U Müller
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

7.  Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.

Authors:  B D Galvin; K C Hart; A N Meyer; M K Webster; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 8.  Neurogenetic diseases: molecular diagnosis and therapeutic approaches.

Authors:  U Muller; M B Graeber
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

Review 9.  Revisiting Crouzon syndrome: reviewing the background and management of a multifaceted disease.

Authors:  Samuel N Helman; Arvind Badhey; Sameep Kadakia; Eugene Myers
Journal:  Oral Maxillofac Surg       Date:  2014-09-24

10.  Mutation analysis of Crouzon syndrome in Taiwanese patients.

Authors:  Chin-Ping Chang; Lei Wan; Chang-Hai Tsai; Cheng-Chun Lee; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.